Table 1.
Dataset of determinations of IgM anti-PC and anti-MDA.
| Samples | Males | Females | Male,% | Cardiovascular comorbidities score, average (min – max) | Average age, all | Average age, males | Average age, females | Anti-PC IgM units (mean ± SD) | Anti-MDA IgM units (mean ± SD) | |
|---|---|---|---|---|---|---|---|---|---|---|
| MCTD | 77 | 11 | 66 | 14.3 | 3.62 (0–15) |
50.4 (18–80) |
56.3 (45–74) |
49.4 (18–80) |
61.51 ± 38.72 | 62.88 ± 33.31 |
| PAPs | 65 | 20 | 45 | 30.8 | 2.98 (0–13) |
48.0 (25–79) |
52.7 (26–67) |
49.9 (25–79) |
87.85 ± 44.26 | 97.59 ± 52.16 |
| RA | 354 | 77 | 277 | 21.8 | 1.32 (0–10) |
58.0 (24–87) |
60.3 (28–83) |
57.4 (24–87) |
88.53 ± 43.68 | 84.34 ± 45.21 |
| SjS | 324 | 21 | 303 | 6.5 | 1.72 (0–10) |
58.3 (22–93) |
59.4 (26–93) |
58.2 (22–86) |
68.73 ± 38.91 | 71.38 ± 37.95 |
| SLE | 374 | 30 | 344 | 8.0 | 2.33 (0–10) |
45.8 (19–87) |
50.0 (23–77) |
45.5 (19–87) |
68.27 ± 36.54 | 76.36 ± 44.35 |
| SSc | 331 | 53 | 278 | 16.0 | 4.84 (0–16) |
58.2 (24–86) |
55.4 (34–84) |
58.7 (24–86) |
76.31 ± 35.90 | 77.04 ± 39.96 |
| UCTD | 118 | 9 | 109 | 7.6 | 2.10 (0–10) |
52.7 (19–90) |
59.7 (44–80) |
52.1 (19–90) |
76.11 ± 43.86 | 83.01 ± 51.82 |
| Control | 515 | 111 | 404 | 21.6 | 0.23 (0–4) |
47.6 (20–85) |
46.3 (25–78) |
48.0 (20–85) |
73.86 ± 34.25 | 69.34 ± 34.24 |